Genta Takes Over Development Of Daiichi Sankyo's Tesetaxel
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
After the oral taxane was put on clinical hold, Genta says it has clear guidance from FDA on how to proceed with development